Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Sales | 1,843 | 1,593 | 659 | 1,100 | 0 |
| Operating Expenses | 14,226 | 20,089 | 10,917 | 18,431 | 6,565 |
| Operating Income | -12,384 | -18,496 | -10,257 | -17,331 | -6,565 |
| Interest Expense | 541 | 236 | 82 | 125 | 363 |
| Other Income | -1,075 | -1,041 | -804 | 203 | -191 |
| Pre-tax Income | -14,000 | -19,774 | -11,144 | -17,253 | -7,119 |
| Net Income Continuous | -14,000 | -19,774 | -11,144 | -17,253 | -7,119 |
| Minority Interests | 4,208 | N/A | N/A | N/A | 0 |
| Net Income | $-9,792 | $-19,774 | $-11,144 | $-17,253 | $-7,119 |
| EPS Basic Total Ops | -0.40 | -0.80 | -0.50 | -0.80 | -0.50 |
| EPS Basic Continuous Ops | -0.40 | -0.80 | -0.50 | -0.80 | -0.50 |
| EPS Diluted Total Ops | -0.40 | -0.80 | -0.50 | -0.80 | -0.50 |
| EPS Diluted Continuous Ops | -0.40 | -0.80 | -0.50 | -0.80 | -0.50 |
| EBITDA(a) | $-11,790 | $-17,941 | $-10,111 | $-16,279 | $-6,349 |